We are live on ! Find out more
VPHM

VIROPHARMA INC
VPHM

Delisted

VPHM was delisted on the 23rd of January, 2014.

Back to rankings

191 hedge funds and large institutions have $2.87B invested in VIROPHARMA INC in 2013 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 63 increasing their positions, 69 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 19

45% more capital invested

Capital invested by funds: $1.98B → $2.87B (+$896M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

10% more funds holding

Funds holding: 174 → 191 (+17)

6% less call options, than puts

Call options by funds: $72.1M | Put options by funds: $76.7M

9% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 69

Holders
191
Holders Change
+17
Holders Change %
+9.77%
% of All Funds
6.19%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
39
Increased
63
Reduced
69
Closed
19
Calls
$72.1M
Puts
$76.7M
Net Calls
-$4.64M
Net Calls Change
-$4.43M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$137M
2
PI
Putnam Investments
Massachusetts
+$119M
3
PC
PointState Capital
New York
+$43.1M
4
MC
Maverick Capital
Texas
+$40.9M
5
PCM
Pentwater Capital Management
Florida
+$40.9M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$96M
2
SCM
Scopia Capital Management
New York
-$39.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$33.3M
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$31.5M
5
PAI
Palo Alto Investors
California
-$28.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
126
PDT Partners
New York
$761K -$815K -24,921 -56%
HK
127
Horizon Kinetics
New York
$746K – – –
Citigroup
128
Citigroup
New York
$726K +$478K +14,630 +378%
QIM
129
Quantitative Investment Management
Virginia
$718K +$598K +18,300 New
BNP Paribas Financial Markets
130
BNP Paribas Financial Markets
France
$712K -$150K -4,585 -20%
CNB
131
City National Bank
California
$696K -$12.8K -393 -2%
DL
132
Delta Lloyd
Netherlands
$672K -$530K -16,200 -49%
AQR Capital Management
133
AQR Capital Management
Connecticut
$635K -$19.6K -600 -4%
PNC Financial Services Group
134
PNC Financial Services Group
Pennsylvania
$597K +$443K +13,555 +827%
Asset Management One
135
Asset Management One
Japan
$579K +$483K +14,772 New
HCM
136
Highbridge Capital Management
New York
$555K +$463K +14,156 New
TD Asset Management
137
TD Asset Management
Ontario, Canada
$538K -$1.11M -33,900 -71%
FAM
138
Fortaleza Asset Management
Illinois
$514K -$228K -6,981 -35%
SG Americas Securities
139
SG Americas Securities
New York
$496K -$289K -8,829 -41%
TAM
140
Tocqueville Asset Management
New York
$489K – – –
AAM
141
Advisors Asset Management
Colorado
$480K -$82.7K -2,529 -17%
N
142
Nuveen
North Carolina
$446K +$11.2K +343 +3%
SCA
143
SAC Capital Advisors
Connecticut
$444K -$1.83M -55,903 -83%
ST
144
Spot Trading
Illinois
$429K +$180K +5,502 +101%
SNC
145
Stifel Nicolaus & Co
Missouri
$417K -$167K -5,113 -32%
TH
146
Timber Hill
Connecticut
$390K +$325K +9,927 New
MSA
147
Mason Street Advisors
Wisconsin
$379K +$19.1K +584 +6%
VKH
148
Virtu KCG Holdings
New York
$363K +$302K +9,234 New
Capital Fund Management (CFM)
149
Capital Fund Management (CFM)
France
$348K +$289K +8,851 New
PI
150
Placemark Investments
Illinois
$341K +$283K +8,659 New
4 5
6
7 8

VPHM Hedge Fund Activity: Q3 2013 in Review

191 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q3 2013, worth a combined $2.87B — up 45% from $1.98B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new VPHM positions and 19 closed out — a net gain of 20 holders — while 63 added to existing stakes and 69 trimmed.

The largest buyer was Westfield Capital Management, adding an estimated $137M. The largest seller was Baker Bros. Advisors, cutting an estimated $96M.

  • 191 institutional investors held VIROPHARMA INC (VPHM) as of Q3 2013, up from 174 in Q2 2013.
  • Funds reported $2.87B of VIROPHARMA INC stock for Q3 2013, up 45% quarter-over-quarter.
  • 39 funds opened new VIROPHARMA INC positions in Q3 2013 and 19 closed out, a net change of +20 holders.
  • The largest VIROPHARMA INC buyer in Q3 2013 was Westfield Capital Management, an estimated $137M added.
  • The largest VIROPHARMA INC seller in Q3 2013 was Baker Bros. Advisors, an estimated $96M sold.

Based on aggregated 13F filings for Q3 2013.